Skip to main content

Table 2 Baseline characteristics of different subsets stratified by baseline APACHE II score

From: Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis

 

Moderate risk ( n = 86)

High risk ( n = 41)

Very high risk ( n = 35)

P valuea

Patient characteristics

    

 Age (years)

67 (57 to 76)

69 (58 to 76)

72 (66 to 78)

0.171

 Male sex

50 (58%)

26 (63%)

17 (49%)

0.419

Illness severity

    

 APACHE II score

19 (16 to 21)

27 (25 to 28)

33 (32 to 36)

<0.001

 SOFA score

9 (7 to 11)

12 (11 to 13)

13 (11 to 15)

<0.001

 Number of dysfunctional organs

3 (2 to 4)

4 (3 to 5)

5 (4 to 5)

<0.001

 Positive blood culture

31 (36%)

23 (56%)

18 (51%)

0.067

 JAAM DIC score

6 (5 to 8)

6 (5 to 8)

8 (6 to 8)

0.092

 ISTH DIC score

4 (3 to 5)

4 (4 to 5)

5 (4 to 5)

0.018

Time from severe sepsis onset to study entry

0.035

 Early (≤48 hours)

53 (62%)

33 (81%)

28 (80%)

 

 Late (>48 hours)

33 (38%)

8 (20%)

7 (20%)

 

Infection site

0.457b

 Lung

17 (20%)

6 (15%)

9 (26%)

 

 Abdomen

35 (41%)

16 (39%)

11 (31%)

 

 Soft tissue

19 (22%)

9 (22%)

3 (9%)

 

 Urinary tract

9 (11%)

5 (12%)

7 (20%)

 

 Other/unknown

6 (7%)

5 (12%)

5 (14%)

 
  1. APACHE, Acute Physiology and Chronic Health Evaluation; DIC, disseminated intravascular coagulation; ISTH, International Society on Thrombosis and Hemostasis; JAAM, Japanese Association for Acute Medicine; SOFA, Sequential Organ Failure Assessment. Data are expressed as group median (interquartile range) or proportions (%). a P value between three subsets in the Kruskal–Wallis or chi-square test. bOnly one P value, for site of infection, is shown because the test was performed as a chi-square test on a 3 × 5 crosstable.